Feasibility of a Memory Support System for Mild Cognitive Impairment
Official title: Implementation of the Memory Support System: A Feasibility Study
Run by Bruyère Health Research Institute. · NCT05999929 · Data updated 2026-11-12
This study is testing a new Memory Support System to see if it can help people with mild cognitive impairment and their caregivers manage daily activities and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Bruyère Health Research Institute. Academic / other |
| Locations | 1 site (Ottawa, Ontario) |
| Status | Recruiting |
| Started | December 17, 2023 |
| Main results expected | March 31, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT05999929 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 50 and older diagnosed with mild cognitive impairment who have regular contact with a care partner.
✕Probably not a fit
Patients with significant visual or hearing impairments or those currently participating in another related clinical trial may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the feasibility of implementing the Memory Support System (MSS) for individuals with mild cognitive impairment (MCI) and their care partners at a clinic in Ontario, Canada. Participants will complete a survey to express their interest and preferred methods for MSS administration, followed by training sessions for a selected group. The study will evaluate various outcomes, including program adherence, self-reported daily living activities, memory self-efficacy, quality of life, mood, anxiety, and caregiver burden. Data will be collected at baseline, post-treatment, and at an 8-week follow-up to inform future MSS implementation.
Why it matters
Potential benefit: If successful, this study could enhance cognitive support and quality of life for patients with mild cognitive impairment and their caregivers.
How similar studies have gone: While similar interventions have been explored, this specific approach to implementing the MSS is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of single or multi-domain MCI * Clinical Dementia Rating global (CDR) score of ≤ 0.5 * Montreal Cognitive Assessment score of ≥18 * available contact with a care partner ≥ 2 times weekly * absence or stable intake of nootropic(s) for ≥ 3 months Exclusion Criteria: * visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training * concurrent participation in another related clinical trial
Where it's running
-
Bruyère Health Research Institute
Ottawa, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Neil Thomas, MD — Bruyère Health Research Institute.
- Study coordinator: Neil Thomas, MD
- Email: nthomas@bruyere.org
- Phone: 613-562-6322
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Choose Myself (Before) Losing Myself
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
-
Gut and Oral Microbiome and Cognitive Health in Aging
This study tests whether differences in gut and mouth bacteria are linked to cognitive health in adults across ages and cognitive status.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
AI-supported sleep program for people with mild cognitive impairment or dementia
A small randomized trial tests an AI-assisted behavioral sleep program to help people with mild cognitive impairment or mild dementia who have sleep problems.
-
Binaural beats for cognitive function in older adults with mild cognitive impairment in nursing homes
This study tests whether listening to 10-Hz binaural beats for 30 minutes daily for 14 days can help cognitive function in older adults with mild cognitive impairment living in nursing homes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.